These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5412585)

  • 1. [Perspectives in the development of drug consumption].
    Fikr V; Federmann J
    Cesk Zdrav; 1970 Jan; 18(1):14-20. PubMed ID: 5412585
    [No Abstract]   [Full Text] [Related]  

  • 2. Achieving a quality drug supply.
    Nelson G
    J Am Pharm Assoc; 1974 Oct; 14(10):548-9, 564. PubMed ID: 4420394
    [No Abstract]   [Full Text] [Related]  

  • 3. Seizures of Canadian drugs rise as Congress, Customs spar.
    Carreyrou J
    Wall St J (East Ed); 2006 Jul; ():B1, B8. PubMed ID: 16909501
    [No Abstract]   [Full Text] [Related]  

  • 4. Economic and policy implications of reimportation: a Canadian perspective.
    Ward C
    Manag Care; 2004 Mar; 13(3 Suppl):17-20. PubMed ID: 15074165
    [No Abstract]   [Full Text] [Related]  

  • 5. [Economic aspects of the long-term development of a variety of drugs in Czechoslovakia].
    Federmann J; Honzáková L
    Cesk Zdrav; 1981 May; 29(5):212-8. PubMed ID: 7249130
    [No Abstract]   [Full Text] [Related]  

  • 6. [Essential drugs available to all].
    Bol Oficina Sanit Panam; 1992; 113(5-6):539-43. PubMed ID: 1296697
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmaceutical expenditure compared across countries.
    van Mosseveld C
    Can J Clin Pharmacol; 2005; 12(3):e269-75. PubMed ID: 16373959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Social problem associated with drugs].
    Palenzona C
    Minerva Med; 1978 Jan; 69(4):271-4. PubMed ID: 625379
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-Glaxo campaign heats up in United States.
    Moynihan R
    BMJ; 2003 Feb; 326(7386):413. PubMed ID: 12595358
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: More on "orphan" drugs.
    Lyle WH
    N Engl J Med; 1975 Apr; 292(15):813-4. PubMed ID: 1113808
    [No Abstract]   [Full Text] [Related]  

  • 11. Industry perspectives on ICH guidelines.
    Rockhold FW
    Stat Med; 2002 Oct; 21(19):2949-57. PubMed ID: 12325111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmaceutical specialities: definitions and rules for manufacturing and marketing in Italy].
    Germani C; Montanari L; Petraroja A
    Boll Chim Farm; 1979 Mar; 118(3):135-43. PubMed ID: 475905
    [No Abstract]   [Full Text] [Related]  

  • 13. Too many drugs?
    Halberstam MJ
    Forum Med; 1979 Mar; 2(3):170-6 concl. PubMed ID: 10316794
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased direct-to-consumer advertising driving pharmaceutical costs, trends.
    Fine A
    Exec Solut Healthc Manag; 1999 Jan; 2(1):2-3. PubMed ID: 10345986
    [No Abstract]   [Full Text] [Related]  

  • 15. Sometimes a "non-returnable" basis for drugs is justified.
    Davis NM
    Hosp Pharm; 1976 Jul; 11(7):254. PubMed ID: 1029731
    [No Abstract]   [Full Text] [Related]  

  • 16. [The cost of drugs].
    Hamel G
    Laval Med; 1968 Jun; 39(6):488-94. PubMed ID: 5679194
    [No Abstract]   [Full Text] [Related]  

  • 17. Access to essential drugs.
    Dev World Bioeth; 2001 Nov; 1(2):89-92. PubMed ID: 12870517
    [No Abstract]   [Full Text] [Related]  

  • 18. Where does drug importation stand now?
    Guglielmo WJ
    Med Econ; 2005 Mar; 82(6):42, 44, 46. PubMed ID: 15869085
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmaceutical industry financial performance.
    Goodman M
    Nat Rev Drug Discov; 2009 Dec; 8(12):927-8. PubMed ID: 19949398
    [No Abstract]   [Full Text] [Related]  

  • 20. The MAC program and wholesale drug prices, a preliminary analysis.
    Dickens PF; Hogan TD
    Res Stat Note; 1977 Jul; (11):1-4. PubMed ID: 10316558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.